Harvard, MIT, Berkeley are still fighting over genome-editing patents. Now another ruling
Who says organic chemistry doesn't have its drama? The US Patent Office's appeal board on Monday sided with Harvard University and MIT by upholding a set of the group's patents covering CRISPR-Cas9 genome editing in plants and animals....